ResearcherUniversity of Science and Technology of ChinaActive in the last 2 years

Yue Yu

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0002-3617-2037; OpenAlex author ID A5100397965.

Their work

Papers: 3 (first author 0, last author 2)
Trials: 0
Grants: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

In situ thermal-responsive hydrogels for combined photothermal therapy and chemotherapy of pancreatic cancer. Last author DOI 10.1039/d5ra00371g ↗
Clinical immunotherapy in pancreatic cancer. Co-author DOI 10.1007/s00262-024-03632-6 ↗
Meta-analysis reveals an association between acute pancreatitis and the risk of pancreatic cancer. Last author DOI 10.12998/wjcc.v8.i19.4416 ↗

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Xiaorong Ye · 1 shared paper, 2024
- Paper Clinical immunotherapy in pancreatic cancer. DOI 10.1007/s00262-024-03632-6 ↗
Hongdi Ma · 1 shared paper, 2024
- Paper Clinical immunotherapy in pancreatic cancer. DOI 10.1007/s00262-024-03632-6 ↗
Ningwei Wang · 1 shared paper, 2025
- Paper In situ thermal-responsive hydrogels for combined photothermal therapy and chemotherapy of pancreatic cancer. DOI 10.1039/d5ra00371g ↗
Jie Liu · 1 shared paper, 2020
- Paper Meta-analysis reveals an association between acute pancreatitis and the risk of pancreatic cancer. DOI 10.12998/wjcc.v8.i19.4416 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.